By screening the NCATS drug library, containing 1978 compounds, we recently reported that TAK-243 (MLN7243), a first-in-class inhibitor of the ubiquitin-activating enzyme UBA1 (also known as UBE1) preferentially suppresses cell proliferation of SLFN11-deficient cancer cells [1]. The gene discussed is SLFN11; the disease is cancer.